v3.26.1
CONSOLIDATED INCOME STATEMENTS
₨ in Millions, $ in Millions
 12 Months Ended
Mar. 31, 2026
INR (₨)
₨ / shares
Mar. 31, 2026
USD ($)
$ / shares
Mar. 31, 2025
INR (₨)
₨ / shares
Mar. 31, 2024
INR (₨)
₨ / shares
Analysis of income and expense [abstract]        
Revenues ₨ 335,933 [1] $ 3,580 ₨ 325,535 [1] ₨ 279,164 [1]
Cost of revenues 158,669 1,691 135,107 115,557
Gross profit 177,264 1,889 190,428 163,607
Selling, general and administrative expenses 106,763 1,137 93,870 77,201
Research and development expenses 24,058 256 27,380 22,873
Impairment of non-current assets, net 3,519 38 1,693 3
Other income, net (7,627) (81) (4,358) (4,199)
Total operating expenses 126,713 1,350 118,585 95,878
Results from operating activities (A) 50,551 539 71,843 67,729
Finance income 7,870 84 7,553 5,705
Finance expense (3,738) (40) (2,829) (1,711)
Finance income, net (B) 4,132 44 4,724 3,994
Share of profit of equity accounted investees, net of tax (C) 134 1 217 147
Profit before tax [(A)+(B)+(C)] 54,817 584 76,784 71,870
Tax expense, net 12,351 132 19,539 16,186
Profit for the year 42,466 452 57,245 55,684
Attributable to:        
Equity holders of the parent company 42,850 456 56,544 55,684
Non-controlling interests ₨ (384) $ (4) ₨ 701 ₨ 0
Earnings per share attributable to equity holders of the parent company        
Basic earnings per share of Rs.1/- each | (per share) [2] ₨ 51.48 $ 0.55 ₨ 67.88 ₨ 66.93 [3]
Diluted earnings per share of Rs.1/- each | (per share) [2] ₨ 51.42 $ 0.55 ₨ 67.78 ₨ 66.8
[1] Revenues for the year ended March 31, 2026 do not include inter-segment revenues from the PSAI segment to the Global Generics segment, of Rs.7,270 (as compared to Rs.9,389 and Rs.10,707 for the years ended March 31, 2025 and 2024, respectively) and from the PSAI segment to the Others segment of Rs.0 (as compared to Rs.0 and Rs.72 for the years ended March 31, 2025 and 2024, respectively)
[2] Earnings per share is computed after giving effect to 1:5 forward stock split effective October 28, 2024 for all periods presented. Refer to Note 19 of these consolidated financial statements for further details regarding such stock split.
[3] Earnings per share is computed after giving effect to 1:5 forward stock split effective October 28, 2024 for all periods presented. Refer to Note 20 of these consolidated financial statements for further details regarding such stock split.